Kristofer J Thurecht
Prof. Kris Thurecht is the interim Executive Director of the Australian Institute for Bioengineering and Nanotechnology at the University of Queensland.
His research is multidisciplinary, working across the boundaries of chemistry and materials, biology, engineering and imaging science, where his team investigates the intricate interplay between structure and function of nanomaterials and how this affects their subsequent interaction with biological entities. In particular, there is a focus on utilising advanced molecular imaging as a realtime measure of how nanomaterials behave and influence biological systems, in particular complex multicellular in vitro systems and also in living animals. Recently, this has expanded into developing and understanding targeted radiopharmaceuticals for both imaging and therapy. This includes the development of a targeted alpha therapy facility at the University of Queensland to explore this emerging class of highly potent radiotherapeutic. Prof. Thurecht is Director of the ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals an Associate Editor for the American Chemical Society journal, Molecular Pharmaceutics and is a member of the ARC College of Experts.
Abstracts this author is presenting: